首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6415篇
  免费   907篇
  国内免费   452篇
耳鼻咽喉   48篇
儿科学   105篇
妇产科学   48篇
基础医学   587篇
口腔科学   153篇
临床医学   806篇
内科学   832篇
皮肤病学   63篇
神经病学   234篇
特种医学   353篇
外国民族医学   1篇
外科学   621篇
综合类   1272篇
现状与发展   1篇
预防医学   469篇
眼科学   95篇
药学   791篇
  10篇
中国医学   796篇
肿瘤学   489篇
  2024年   43篇
  2023年   252篇
  2022年   511篇
  2021年   651篇
  2020年   479篇
  2019年   375篇
  2018年   331篇
  2017年   348篇
  2016年   290篇
  2015年   473篇
  2014年   462篇
  2013年   469篇
  2012年   575篇
  2011年   540篇
  2010年   366篇
  2009年   281篇
  2008年   266篇
  2007年   188篇
  2006年   152篇
  2005年   124篇
  2004年   69篇
  2003年   61篇
  2002年   51篇
  2001年   49篇
  2000年   29篇
  1999年   25篇
  1998年   29篇
  1997年   32篇
  1996年   28篇
  1995年   19篇
  1994年   15篇
  1993年   16篇
  1992年   5篇
  1991年   15篇
  1990年   13篇
  1989年   17篇
  1988年   17篇
  1987年   11篇
  1986年   12篇
  1985年   14篇
  1984年   7篇
  1983年   7篇
  1982年   8篇
  1981年   12篇
  1980年   8篇
  1979年   3篇
  1978年   6篇
  1977年   7篇
  1976年   4篇
  1975年   7篇
排序方式: 共有7774条查询结果,搜索用时 31 毫秒
61.
为探讨实时三维超声心动图(RT-3DE)定量评估心梗患者经皮冠状动脉介入治疗(PCI)术前后左室收缩功能及同步性参数的变化,选取100例接受PCI治疗的心肌梗死患者和100例正常对照组,应用RT-3DE技术对正常对照组和心梗患者PCI术前及术后1个月测量左心室收缩功能及同步性参数并进行比较。心梗患者PCI术前组左心室各功能参数值均劣于正常对照组,而术后1个月左心室各参数值均较术前明显改善。PCI术前、术后应用RT-3DE能够准确定位、定量反映左心室收缩功能及运动同步性,对心肌梗死的临床诊断及疗效评估具有重要价值。  相似文献   
62.
鼠李属植物提取物的药用价值研究现状   总被引:1,自引:0,他引:1  
鼠李属植物作为传统中药,其应用仅局限于作为民间配方辅助治疗一些疾病。本文通过对其抗菌性、抗氧化性、抗过敏性及抗肿瘤的相关文献进行归纳,探讨鼠李属植物的潜在药用价值。  相似文献   
63.
64.
This study aimed to evaluate the efficacy of FOLFOX6, SOX and XELOX as neoadjuvant chemotherapy for advanced gastric cancer. The study retrospectively assessed clinicopathological data of patients who received a radical D2 gastrectomy for gastric cancer from January 2010 to January 2013.The patients were either not administered neoadjuvant chemotherapy (control) or were given FOLFOX6, SOX and XELOX prior to surgery. The metastatic rate was also higher for the control group compared with the three chemotherapy regimens in N2 station lymph nodes (P?P?相似文献   
65.
Background:In recent years, the incidence rate of hypertensive nephropathy has been increasing quickly, which has been a major threat to people''s health. Renin-angiotensin-aldosterone system blockers have certain curative effects. However, there are some patients having serious adverse reactions, and the benefit population is limited, so the treatment of hypertensive renal damage is necessary to have beneficial supplement. More and more clinical studies have shown that ginkgo leaf extract and dipyridamole injection (GDI) combined with antihypertensive drugs has achieved good results in the treatment of hypertensive renal damage. It is supposed to be a supplementary treatment in hypertensive nephropathy.Objectives:To systematically assess the efficacy and safety of GDI combined with antihypertensive drugs on hypertensive renal injury.Methods:Seven databases including PubMed, Cochrane Library, Embase, Wanfang database, China biomedical literature service system (Sino Med), VIP Chinese Sci-tech journal database (VIP), and China national knowledge internet (CNKI) were retrieved to collect randomized controlled trials (RCTs) in the experimental group containing combined therapy of hypertensive nephropathy with GDI and antihypertensive drugs. The retrieval time was from the establishment of database to July 8, 2020. Two researchers independently selected literature, extracted data, and evaluated the risk of bias in the study. The methodological quality was evaluated with Cochrane handbook and meta-analysis was performed with Stata 14.0 software.Results:Eight studies were included in this study which involved 556 patients. The meta-analyses indicated that, compared with using antihypertensive drugs alone, combined treatment of GDI with antihypertensive drugs can decrease 24-hour urinary total protein (weighted mean difference [WMD] –0.61, 95% confidence interval [CI]: –0.82, –0.39; k = 6, P ≤ .001), blood urea nitrogen (WMD –1.27, 95% CI: –2.45, –0.10; k = 6, P = .033, serum creatinine (WMD –29.50, 95% CI: –56.44, –2.56; number of estimates [k] = 6, P = .032).Conclusions:Our meta-analyses showed that GDI combined with antihypertensive drugs can improve the renal function of hypertensive patients with renal injury.  相似文献   
66.
67.
BackgroundNeuropathic pain is a multifaceted and ubiquitous disease across the globe. Mood disorders, such as anxiety and depression, are frequently observed in patients suffering from neuropathic pain. Both neuropathic pain and comorbid mood disorders seriously impact quality of life. Accumulated evidence shows that activation of the NOD-like receptor protein 3 (NLRP3) inflammasome is involved in the neuroinflammatory pathogenesis of neuropathic pain, anxiety, and depression. However, the role of the NLRP3 inflammasome in the pathological process of anxiety and depression under the neuropathic pain state has not been fully described. Albiflorin, a monoterpene glycoside, may be a potential regulator of the NLRP3 inflammasome, but it is not clear whether albiflorin relates to NLRP3 inflammasome activation.MethodsWe used a systematic pharmacological method to confirm whether the activation of the NLRP3 inflammasome in the hippocampus was involved in the development of neuropathic pain associated with mood disorders and whether albiflorin could be an effective treatment for these symptoms.ResultsThe NLRP3 inflammasome contributed to the neuropathic pain and comorbid anxiety and depression-like behaviors induced by chronic constriction injury of the sciatic nerve, and albiflorin may relieve these symptoms via inhibition of the NLRP3 inflammasome activity. Moreover, albiflorin enhanced the translocation of the nuclear factor erythroid 2-related factor 2 into the nucleus and suppressed nuclear factor-kappa B activity in the hippocampus.ConclusionsAlbiflorin, as a potential therapeutic agent, might greatly improve the overall symptoms of neuropathic pain.  相似文献   
68.
BackgroundBone mineral density (BMD) may be an important factor affecting the clinical outcomes after total knee arthroplasty (TKA). However, further information regarding BMD in postoperative pain relief is not present yet. This study aims to gain further insight into the predictive significance of BMD in postoperative pain relief in knee osteoarthritis (KOA) patients after TKA.Methods156 KOA patients treated by TKA were included in this study. Visual analogue scale (VAS) was used to measure the pain intensity in patients within one year after TKA. The patients were divided into good pain relief group (the improvement of VAS ≥ 3) and poor pain relief group (the improvement of VAS < 3). BMD and other clinical characteristics were also collected. Logistic regression analysis and receiver operating characteristic curve (ROC curve) were used to evaluate the predictive significance of BMD. Subgroup analysis was used to compare the difference of postoperative pain between High BMD group and Low BMD group extra.Results34 (21.8%) patients had poor pain relief after TKA. Logistic regression analysis indicated that age, BMD, preoperative hospital for special surgery (HSS) scores, preoperative VAS score and postoperative posterior slope angles (PSA) were the risk factors of poor pain relief (P < 0.05). Using BMD as a predictor, the optimum cut-off value of poor pain relief was T-level = ?3.0 SD in the ROC curve, where sensitivity and specificity were 73.5% and 83.7%, respectively. Based on this cut-off value, obvious pain relief was observed in the High BMD group compared with Low BMD group from the 6th month after TKA in the subgroup analysis (P < 0.05).ConclusionsBMD is an effective predictor for postoperative pain relief in KOA patients after TKA, and the poor pain relief should be fully considered especially when BMD T-level ≤ ?3.0 SD.  相似文献   
69.
隗继武教授在长期的临床、教学、科研中积累了丰富的经验,善于通过调理脾胃治疗疑难杂病,他紧抓脾胃特点,重视辨证用药、药物配伍及脏腑关系,用药审慎求精,临床疗效显著。  相似文献   
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号